​

Puma Bio (PBYI) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

PBYI Stock Rating

Puma Bio stock's rating consensus is Buy, based on 17 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 8 Buy (47.06%), 6 Hold (35.29%), 3 Sell (17.65%), and 0 Strong Sell (0.00%).

Buy
Total 17 0 3 6 8 Strong Sell Sell Hold Buy Strong Buy

PBYI Price Target Upside V Benchmarks

TypeNameUpside
StockPuma Bio-
SectorHealthcare Stocks 24.81%
IndustryBiotech Stocks 65.78%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$3.54$3.54$3.54
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 25--1-12
May, 251-1-13
Apr, 251-1-13
Mar, 251-1-13
Feb, 251-1-13
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 26, 2024Edward JonesUnderperformUnderperformhold
Jun 04, 2024Edward JonesUnderperformUnderperformhold

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.52$-0.72$0.02$0.46$0.62----
Avg Forecast$-1.41$-0.87$0.17$0.49$0.30$0.34$0.31$-0.20$-0.35
High Forecast$-1.35$-0.83$0.17$0.52$0.31$0.45$0.66$-0.19$-0.34
Low Forecast$-1.45$-0.90$0.17$0.47$0.29$0.27$-0.04$-0.21$-0.36
Surprise %7.80%-17.24%-88.24%-6.12%106.67%----

Revenue Forecast

$185M $199M $213M $227M $241M $255M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$225.10M$253.20M$228.00M$235.64M$230.47M----
Avg Forecast$225.38M$245.09M$219.41M$237.05M$223.90M$221.35M$227.10M$200.00M$195.00M
High Forecast$231.12M$251.33M$224.05M$237.87M$223.93M$222.54M$233.41M$205.56M$200.42M
Low Forecast$219.03M$238.19M$214.76M$236.33M$223.87M$220.15M$220.78M$194.43M$189.57M
Surprise %-0.12%3.31%3.92%-0.60%2.93%----

Net Income Forecast

$-200M $-150M $-100M $-50M $0 $50M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-60.00M$-29.10M$912.00K$21.59M$30.28M----
Avg Forecast$-46.05M$-41.20M$-146.58M$21.59M$14.41M$19.95M$19.55M$-9.51M$-16.64M
High Forecast$-34.07M$-39.69M$-117.27M$25.91M$14.85M$21.36M$31.32M$-9.17M$-16.04M
Low Forecast$-58.03M$-42.56M$-175.90M$17.27M$13.97M$12.99M$-1.84M$-9.85M$-17.24M
Surprise %30.29%-29.37%-100.62%-110.11%----

PBYI Forecast FAQ

Is Puma Bio stock a buy?

Puma Bio stock has a consensus rating of Buy, based on 17 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 8 Buy, 6 Hold, 3 Sell, and 0 Strong Sell, reflecting a consensus that Puma Bio is a favorable investment for most analysts.

What is Puma Bio's price target?

Puma Bio's price target, set by 17 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $3.54.

How does Puma Bio stock forecast compare to its benchmarks?

Puma Bio's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (24.81%) and underperforming the biotech stocks industry (65.78%).

What is the breakdown of analyst ratings for Puma Bio over the past three months?

  • June 2025: 0% Strong Buy, 0% Buy, 50.00% Hold, 0% Sell, 50.00% Strong Sell.
  • May 2025: 33.33% Strong Buy, 0% Buy, 33.33% Hold, 0% Sell, 33.33% Strong Sell.
  • April 2025: 33.33% Strong Buy, 0% Buy, 33.33% Hold, 0% Sell, 33.33% Strong Sell.

What is Puma Bio’s EPS forecast?

Puma Bio's average annual EPS forecast for its fiscal year ending in December 2025 is $0.34, marking a -45.16% decrease from the reported $0.62 in 2024. Estimates for the following years are $0.31 in 2026, $-0.2 in 2027, and $-0.35 in 2028.

What is Puma Bio’s revenue forecast?

Puma Bio's average annual revenue forecast for its fiscal year ending in December 2025 is $221.35M, reflecting a -3.96% decrease from the reported $230.47M in 2024. The forecast for 2026 is $227.1M, followed by $200M for 2027, and $195M for 2028.

What is Puma Bio’s net income forecast?

Puma Bio's net income forecast for the fiscal year ending in December 2025 stands at $19.95M, representing a -34.11% decrease from the reported $30.28M in 2024. Projections indicate $19.55M in 2026, $-9.51M in 2027, and $-16.643M in 2028.